Complementary DNA of IL-6 was successfully cloned by Hirano et al. in 1986 [8] and the resultant molecule was found to be identical to hybridoma growth factor (HGF), which derives its name from its promotion of growth of fusion cells with myeloma, to hepatocyte-stimulating factor (HSF) with its promotion of synthesis of acute phase proteins such as C-reactive protein (CRP), serum amyloid A (SAA), haptoglobin, fibrinogen, and hepcidin in hepatocytes, or to interferon (IFN)β2 due to its IFN anti-viral activity [9–11]. Here, CRP is linked to plasma cell myeloma.